Drug information and patients satisfaction in triple therapy for chronic hepatitis C

被引：0
|
作者：
Canamares-Orbis, I. [1 ]
Garcia-Munoz, C. [1 ]
Caro-Teller, J. M. [1 ]
Escribano-Valenciano, I. [1 ]
Gomez-Valbuena, I. [1 ]
Campo-Angora, M. [1 ]
Ferrari-Piquero, J. M. [1 ]
机构：
[1] Univ Hosp 12 Octubre, Madrid, Spain
来源：
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY | 2013年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1316 / 1316
页数：1
相关论文
共 50 条
  • [31] Life and illness satisfaction for patients with chronic Hepatitis C.
    Hilsabeck, RC
    Hassanein, TI
    Perry, W
    GASTROENTEROLOGY, 2000, 118 (04) : A1447 - A1447
  • [32] Recreational Drug and Psychosocial Profile in Chronic Hepatitis C Patients Seeking Antiviral Therapy
    George, Nayana
    Harrell, Sherrie M.
    Rhodes, Kimberly D.
    Duarte-Rojo, Andres
    ANNALS OF HEPATOLOGY, 2018, 17 (01) : 76 - 84
  • [33] Pretreated hepatitis C virus patients candidates for triple therapy
    De Puig, E.
    Perpinya, M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (05) : 990 - 990
  • [34] INPATIENT CARE OF HEPATITIS C PATIENTS CANDIDATE FOR TRIPLE THERAPY
    Ergul, Bilal
    Sarikaya, Murat
    Dogan, Zeynal
    Filik, Levent
    GASTROENTEROLOGY NURSING, 2013, 36 (03) : 232 - 232
  • [35] Treatment of chronic hepatitis B/C coinfected patients with consensus interferon/ribavirin/lamivudine triple therapy
    Kaiser, S
    Hass, HG
    Gregor, M
    JOURNAL OF HEPATOLOGY, 2003, 38 : 148 - 148
  • [36] Assessment of outcomes of triple combination therapy including telaprevir in treating chronic hepatitis C in hemodialysis patients
    Aksoz, S.
    Kaya, S.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 : 88 - 89
  • [37] Renal Impairment Is Frequent in Chronic Hepatitis C Patients Under Triple Therapy With Telaprevir or Boceprevir Reply
    Gordon, Stuart C.
    Yee, Leland J.
    Martins, Eduardo Bruno
    HEPATOLOGY, 2014, 59 (06) : 2427 - 2427
  • [38] Triple therapy of initial high-dose interferon with ribavirin and amantadine for patients with chronic hepatitis C
    Uyama, Hirokazu
    Nakamura, Hideji
    Hayashi, Eijiro
    Ogawa, Hiroyuki
    Enomoto, Hirayuki
    Yoshida, Kenya
    Okuda, Yorihide
    Yamamoto, Mitsunari
    Hada, Toshikazu
    Hayashi, Norio
    HEPATOLOGY RESEARCH, 2007, 37 (05) : 325 - 330
  • [39] Therapeutic drug monitoring of telaprevir in chronic hepatitis C patients receiving telaprevir-based triple therapy is useful for predicting virological response
    Furusyo, Norihiro
    Ogawa, Eiichi
    Murata, Masayuki
    Toyoda, Kazuhiro
    Ohnishi, Hachiro
    Eiraku, Kunimitsu
    Shimizu, Motohiro
    Harada, Yuji
    Mitsumoto, Fujiko
    Takayama, Koji
    Kainuma, Mosaburo
    Okada, Kyoko
    Hayashi, Jun
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2014, 69 (02) : 483 - 490
  • [40] Effects of triple-drug therapy with nitazoxanide, high-dose ribavirin and peginterferon-α-2a in patients with chronic hepatitis C
    Basu, P. Patrick
    Rayapudi, Krishna
    Shah, Niraj James
    Krishnaswamy, Nithya
    Brown, Robert S.
    HEPATOLOGY RESEARCH, 2013, 43 (06) : 589 - 595
12345